Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease

Published:2002-03 Issue:3 Volume:16 Page:399-406
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Sands B. E.,Winston B. D.,Salzberg B.,Safdi M.,Barish C.,Wruble L.,Wilkins R.,Shapiro M.,Schwertschlag U. S.,

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2002.01179.x/fullpdf

Reference27 articles.

1. Inflammatory bowel disease: etiology and pathogenesis;Fiocchi;Gastroenterology,1998

2. Treatment of inflammatory bowel disease from now to the millennium;Cole;Baillieres Clin Gastroenterol,1994

3. Intestinal epithelial hyperpermeability. Mechanisms and relevance to disease;Unno;Gastroenterol Clinics North Am,1998

4. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease;Mayer;Gastroenterology,1991

5. Review article: Chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease?;Van Deventer;Aliment Pharmacol Ther,1997

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease;Expert Opinion on Therapeutic Targets;2024-01-23

2. Understanding interleukin 11 as a disease gene and therapeutic target;Biochemical Journal;2023-12-06

3. Restoration of IL-11 and IL-15 cytokine production post calcium modulators and ROS treatment can assist viral clearance both in vitro and in vivo;IRAN J BASIC MED SCI;2023

4. Interleukin 11 confers resistance to dextran sulfate sodium-induced colitis in mice;iScience;2023-02

5. IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues;International Journal of Molecular Sciences;2022-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3